Cite
MLA Citation
F. Macbeth and L. Hughes-Davies. “Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy – No.” Clinical oncology, vol. 33, no. 12, 2021, pp. 749–750. http://access.bl.uk/ark:/81055/vdc_100145646584.0x00002a